Your browser doesn't support javascript.
loading
TANK-Binding Kinase 1 Mutation as a Rare Cause of Frontotemporal Dementia in a Mexican Patient: The First Case Report in a Tertiary Referral Hospital in Mexico.
Estrada-Rodriguez, Humberto; Meza-Martinez, Daniel A; Muñuzuri-Camacho, Marco Antonio; Garcia-Romero, David; Reyes-Melo, Isael.
Afiliación
  • Estrada-Rodriguez H; Neurology and Psychiatry Department, National Institute of Medical Sciences and Nutrition, Mexico City, MEX.
  • Meza-Martinez DA; Cirugía General, Instituto Mexicano del Seguro Social, Hospital General de Zona No. 33, Monterrey, MEX.
  • Muñuzuri-Camacho MA; Neurocirugía, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Ciudad de Mexico, MEX.
  • Garcia-Romero D; Christus Muguerza Hospital, Autonomous University of Nuevo Leon, Monterrey, MEX.
  • Reyes-Melo I; Neurology and Psychiatry Department, National Institute of Medical Sciences and Nutrition, Mexico City, MEX.
Cureus ; 15(8): e43954, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37622054
Frontotemporal dementia (FTD) is a heterogeneous condition characterized by changes in behavior, personality, and language resulting from degeneration of the frontal and/or temporal lobes. A wide spectrum of clinical syndromes and an overlap with different motor disorders make this entity challenging for clinicians, both in achieving a correct diagnosis and providing proper treatment. Despite the majority of cases being sporadic, FTD has a hereditary component, and more than 10 disease-causing genes have been identified. We present the case of a Mexican patient with a positive family history of neurocognitive disorders who developed early-onset behavioral symptoms, cognitive alterations, and motor disturbances. After a comprehensive study and multiple assessments by various medical services, a molecular diagnosis was achieved by documenting a loss-of-function mutation in the TANK-binding kinase 1 (TBK1) gene, an extremely rare cause of FTD. Genetic diagnosis is crucial in these situations, as this mutation has been associated with rapid disease progression and the potential development of motor syndromes during its course. Our case underscores the challenges involved in reaching an accurate diagnosis, highlighting the importance of molecular testing. A thorough family history, past medical records, and a detailed description of symptom onset and progression are imperative, as they can significantly influence both treatment approaches and prognosis. Diagnostic errors, combined with their subsequent inappropriate treatment, can further deteriorate patients' quality of life.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies País/Región como asunto: Mexico Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies País/Región como asunto: Mexico Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article